皮肤科医生使用诊断基因表达特征测试来指导患者管理的临床影响研究
Alexander Witkowski1, Abel D Jarell2, Kelli L Ahmed3
1Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
Melanoma management
|May 30, 2024
概括
基因表达特征 (GEP) 测试有助于皮肤科医生管理模两可的皮肤病变. GEP的结果影响了治疗决策,增加了对患者管理计划的信心.
科学领域:
- 皮肤病学 皮肤病学
- 分子诊断学 分子诊断学
- 在瘤学瘤学.
背景情况:
- 皮肤黑色细胞新生瘤带来了诊断上的挑战.
- 这些病变的临床模两可使患者的管理变得复杂.
研究的目的:
- 评估基因表达特征 (GEP) 结果对临床决策的影响.
- 评估GEP在诊断上模两可的黑色细胞瘤的管理中的作用.
主要方法:
- 皮肤科医生审查了六个随机的病例场景,包括和没有GEP结果.
- 管理变化根据GEP发现 (良性或恶性) 进行评估.
主要成果:
- 在84.2%的病例中,良性GEP结果导致手术利率下降.
- 恶性GEP结果导致100%的病例增加了外科切除.
- GEP的结果改善了临床医生对管理计划的信心.
结论:
- 诊断GEP测试有效指导对模两可的黑色细胞瘤的临床决策.
- 在临床病理学上不一致的场景中,GEP增强了管理策略.
相关概念视频
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121


